Ortho Regenerative Technologies Inc. announced the appointment of Philippe Deschamps as its new Chief Executive Officer following the retirement of Mr. LeDuc, the company's CEO for the last three years. M. LeDuc will continue as an advisor to the company to ensure a smooth transition and continuity regarding the ongoing projects. Both changes are effective March 15, 2022.

Philippe Deschamps is an experienced Healthcare Executive who has served as CEO of three companies over the last 20 years. The depth of his expertise stems from his 36 years in the Life Sciences industry spent at Bristol Myers Squibb, GSW Worldwide, a leading healthcare commercialization company, and Helius Medical Technologies, a NeuroTech company. As co-founder and CEO of Helius Medical Technologies, Mr. Deschamps took the company public on both the TSXV and NASDAQ stock exchanges and raised $100 million to commercialize their Neurotech product PoNS.

The product gained approval in both Canada and the US. At GSW, Mr. Deschamps was President and CEO and was responsible for the GSW expansion into a Worldwide operation to support the globalization of Pharma.